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Abstract
RhoA and RhoC GTPases share 92% amino acid sequence identity, yet play different roles in regulating cell motility
and morphology. To understand these differences, we developed and validated a biosensor of RhoC activation
(RhoC FLARE). This was used together with a RhoA biosensor to compare the spatio-temporal dynamics of RhoA
and RhoC activity during cell protrusion/retraction and macropinocytosis. Both GTPases were activated similarly at
the cell edge, but in regions more distal from the edge RhoC showed higher activation during protrusion. The two
isoforms differed markedly in the kinetics of activation. RhoC was activated concomitantly with RhoA at the cell edge,
but distally, RhoC activation preceded RhoA activation, occurring before edge protrusion. During macropinocytosis,
differences were observed during vesicle closure and in the area surrounding vesicle formation.
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Introduction
The Rho GTPase phylogenetic subfamily in mammals is
comprised of RhoA, RhoB and RhoC, which share 85% overall
amino acid identity. Northern blotting indicates that all are
ubiquitously expressed, though expression levels vary greatly
[1]. Although RhoA and RhoC share 92% identity, they have
markedly different roles in motility and cancer. RhoA regulates
actin polymerization, Rac activity, and actomyosin contractility
[2–4] while RhoC has primarily been linked to formin-mediated
protrusion, invadopodia and cancer cell invasion[4–7]. RhoA
and RhoC have reciprocal roles in controlling cancer cell
motility. RhoC knockdown has been effective in suppressing
metastasis in xenograft models [8], while knockdown of RhoA
leads to enhanced invasion [5]. In cell culture models,
activators of RhoC induce loss of cell polarity and increase
invasion, while activation of RhoA inhibits invasiveness as well
as motility [5]. To better understand these differential functions
of RhoA and RhoC we developed a biosensor for RhoC, and
used it together with an established RhoA biosensor [9,10] to
elucidate the different spatio-temporal dynamics of RhoA and
RhoC during protrusion and macropinocytosis.
Materials and Methods
Biosensors
RhoC FLARE was created by linking ROCK1 residues
905-1046 to monomeric Cerulean [11], an unstructured linker
of optimized length [12], monomeric Venus [13], and full-length
RhoC (Figure S1; Appendix S1). The construct was subcloned
into pTriEX-HisMyc4 (Novagen) for transient expression. For
linker optimization, repeating units of
TSGSGKPGSGEGSTKGGS were cloned between the two
fluorescent proteins and tested for optimal FRET/CFP ratio
change. We found that a biosensor with 4 linkers produced the
largest dynamic range. Characterization of biosensor
responses was carried out as described previously [9]. Briefly,
HEK293T cells were plated overnight at 1.25x106 cells/well of
6-well plates coated with poly-L-lysine, and transfected using
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Lipofectamine2000 reagent (Invitrogen) following the
manufacturer’s protocols. The biosensor and the regulator
cDNAs were co-transfected at ratios of 1:4 for the biosensor
and the GDI or the GAP and 1:4:1 - 10 for the
biosensor:GDI:GEF. Forty eight hours following the
transfection, cells were trypsinized and suspended in ice cold
PBS, and then placed directly into fluorometric cuvettes to
measure fluorescence emission spectra. The spectra were
obtained by exciting cold, live, 293 cell suspensions in the
cuvette with 433nm light, with emission scanned from 450 -
600nm. The fluorescence reading of a sample cell suspension
with empty cDNA (pCDNA3.1) was used to measure light
scatter and autofluorescence, which were subtracted from the
data. The resulting spectra were normalized to the peak CFP
emission intensity to generate the final ratiometric spectra.
Cell culture
MEF/3T3 (Clontech) were maintained in Dulbecco’s modified
Eagle’s medium (Gibco) with 10% FBS. To induce RhoA
biosensor expression, 2µg/ml doxycycline was removed 48
hours prior to imaging by detaching cells through brief
trypsinization and then replating them at 104 cells per 10cm
dish. A stable cell line expressing RhoC was produced using a
tet-inducible retroviral system as previously described [9]. Cells
were plated on fibronectin-coated glass coverslips (10 μg/ml)
for 3 hours prior to imaging. Imaging was performed in Ham’s
F-12K without phenol red (Biosource), 10 mM HEPES and with
2% FBS in a heated closed chamber. For serum-stimulation
experiments, cells were starved for 24hrs in medium containing
0.5% serum, and stimulated with medium containing 10%
serum.
Imaging
Activation levels of RhoA and RhoC were measured by
monitoring the ratio of ECFP or mCerulean emission to FRET
emission. Images were acquired using a custom microscope
capable of simultaneous acquisitions of FRET with either ECFP
or mCerulean, through two CoolsnapES2 cameras mounted via
a beamsplitter. The specifications of this imaging system are
detailed elsewhere [14]. Images acquired by this two camera
system were properly aligned using a priori calibration and
morphing to achieve accurate pixel-by-pixel matching as
described previously [15]. Image processing, ratio calculations
and correction for photobleaching were as described previously
[9].
Morphodynamic correlation and computational
multiplexing analysis
To analyze the spatiotemporal correlation of RhoC and RhoA
activity with cell edge motion, activities were sampled in
reporter windows of 2.5 µm width and 0.9 µm depth,
maintained at a constant distance from the cell edge. Windows
were sampled at different distances from the edge, in steps of
0.9 µm. In addition, the velocity of the edge was determined,
enabling the correlation of signaling and morphodynamic
activity in a cell-frame of reference amenable to statistical
comparisons, as previously described [16]. Temporal cross-
correlation between RhoC or RhoA activity and edge velocity
was determined for all reporter windows, examining correlation
at time differences up to a maximum of 500 seconds (50
frames). Characteristic cross-correlations between RhoA or
RhoC activation and edge velocity were estimated by fitting a
smoothing spline to the combined pool of cross-correlations.
The variance and 95% confidence interval of the smoothing
spline approximation, and hence of the location of the
maximum correlation, was calculated using a non-parametric
bootstrap method [17]. Because of the invariance of the
reporter window shape, sampling data from multiple cells could
be pooled in this analysis. The “timelag” as calculated and
presented is the highest peak of the cross-correlation trace at a
given distance from the edge. The region within 0 - 3 pixels
from the edge usually contains significant errors due to
fluorescence image threshold masking from the associated
lower signal to noise ratio at the edge. Thus we considered the
region 3 - 6 pixels from the edge as the beginning of reliable
edge measurements in our correlation analysis.
Results and Discussion
The design of the new RhoC biosensor was similar to that of
our previously published biosensor for RhoA [9], but
incorporating RhoC , a different set of linkers, and a binding
domain from ROCK1 (RBD, amino acids 905-1046) that
preferentially binds to GTP-loaded RhoC [18]. The domain, at
the amino terminus of the biosensor, was fused to monomeric
Cerulean fluorescent protein [11], followed by an optimized
linker, monomeric Venus [13], and finally full-length RhoC.
Upon GTP-loading, the RBD bound to the RhoC, increasing
FRET (Figure 1A). The two fluorophores were placed on the
internal portion of the biosensor chain, leaving the C-terminus
of the GTPase intact for binding and regulation by Rho guanine
nucleotide dissociation inhibitor (RhoGDI). Consistent with
recent nomenclature we have introduced to differentiate
biosensor designs, the new biosensor is named RhoC
FLARE.sc (sc denotes a single chain design) [19,20].
The size of the biosensor precluded purification for in vitro
characterization, so it was expressed and analyzed in
suspensions of HEK cells (Figure 1B-E). The biosensor
showed a 41% increase in FRET ratio between inactive and
constitutively active mutants (T19N versus Q63L and G14V
respectively), with wt biosensor subject to regulation in the cells
and therefore responding between these two extremes. The
biosensor was expressed in HEK293T cells (see M&M) at high
levels to produce sufficient signal for fluorometry of cell
suspensions. At these expression levels, cellular negative
regulators including endogenous GDI were overwhelmed
[9,21], as endogenous ratios of Rho GTPases to GDI in most
cells are 1:1 or at most 1:1.1 [22]. Excess wildtype biosensor
was observed to translocate to the plasma membrane, where it
could encounter active GEFs and become activated. This
resulted in the observed high levels of FRET [9]. This effect
was reversed by expressing GDI together with the biosensor.
The GDI cDNA concentration was titrated (data not shown) to
the lowest possible GDI expression levels that could produce
maximal suppression of biosensor activity (1:4 ratio of
biosensor:GDI cDNA during transfection). This treatment
RhoA/C Biosensors in Cell Protrusion
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affected the biosensor that had an activating mutation known to
be sensitive to GDI (G14V), but not the Q63L mutant that does
not bind GDI [22]. Figure 1C shows that GDI effects could be
counteracted by expressing excess guanine nucleotide
exchange factors (GEFs), but only when using GEFs or GEF
fragments that were specific for Rho (DH-PH, activated GEF
fragments from Dbs and Dbl, but not from Tiam1 and ITSN
[23]). In these fluorometric validation measurements, we
overexpressed either full-length or truncated, constitutively
active GEF fragments in HEK293T cells. At the high expression
levels used it was likely that GEFs were not normally localized,
overwhelming native binding sites. In contrast, during later
imaging of adherent cells, when expression was kept at the
lowest levels providing acceptable signal/noise, endogenous
GEFs activated the biosensors. This led to localized GEF
interactions, which has been previously shown to impart
selectivity for activating RhoA versus RhoC [7,24]. In the cell
suspension assays, the fluorescence ratio of the wild type
biosensor was also reduced by p50RhoGAP in the absence of
excess GDI. Together these data demonstrate robust response
of the biosensor to RhoC activation, and specific response to
the three major classes of regulatory proteins: GEFs, GAPs
and GDI. Unlike Rho family biosensors that are anchored
permanently to the plasma membrane, the intact GTPase C
terminus in RhoC FLARE as well as in the previous RhoA
biosensor allows for interaction with GDI. This is important
because it enables our biosensor to reflect control of activation
through translocation between the cytoplasm and the plasma
membrane [9], which requires interaction with GDI. The FLARE
biosensors therefore report GTPase activation rather than the
balance of GEF/GAP activity at the plasma membrane.
We examined whether XPLN, the GEF previously reported to
activate RhoA but not RhoC [25], could differentiate between
our RhoA [9] and RhoC FLARE biosensors. RhoA activity was
rescued upon overexpression of full length XPLN in cells
expressing RhoA sensor together with GDI (at a cDNA
Figure 1.  Construction and validation of the RhoC FLARE biosensor.  (A) Design of the biosensor (B) Analysis of cell
suspensions expressing biosensor mutants. RhoC G14V but not Q63L is susceptible to Rho GDI. Data shown with S.E.M. n=3. (C)
RhoC biosensor cell suspensions co-expressing Rho GEFs (Dbs, Dbl), Rac-specific GEF Tiam1 and Cdc42-specific GEF
intersectin. Results were normalized to wildtype=1, mean of at least three independent experiments. Error bars represent standard
error of the mean, ** = P < 0.001 and * = P < 0.05 (t-test, one-tailed), for B and for C. (D) 293T cell suspensions expressing RhoC
biosensor with (dashed curve) or without (solid curve) RhoGDI coexpression (excitation at 433 nm). (E) RhoA and RhoC biosensor
cell suspensions co-expressing Rho GDI and the RhoA/B-specific GEF XPLN. The normalized emission ratio of a negative control
biosensor harboring p21 binding domain (PBD) of p21 activated kinase 1 (PAK1) instead of the Rho binding domain (RBD) from
ROCK is shown in the absence of GDI overexpression. * = p < 0.001 (t-test, one-tailed), n=3, data shown with SEM.(F) Raw
emission ratios of cells stably expressing wildtype RhoC FLARE.sc or control RhoC-PBD biosensors following serum stimulation for
the indicated timepoints. * = p < 0.05 compared to t=0 (t-test, one-tailed), n=10 at each time point, data shown with SEM.
doi: 10.1371/journal.pone.0079877.g001
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transfection ratio 1:4:4 for biosensor:GDI:XPLN) (Figure 1E).
The same overexpression condition had only modest effects on
the RhoC biosensor response. We tested for the specificity of
the binding domain used in the RhoC biosensor by changing
the Rho kinase binding domain to the p21 binding domain
(PBD) from p21 activated kinase 1 (PAK1), a downstream
target of Rac1 and Cdc42 [26]. Even in the absence of
exogenous GDI, this control biosensor showed a FRET ratio
similar to that produced when the normal biosensor was
exposed to excess GDI (Figure 1E).
We examined response of the RhoC biosensor to exogenous
stimulation [27], using mouse embryonic fibroblasts (MEFs)
stably expressing either the wildtype RhoC biosensor or the
PBD-control version of the biosensor under an inducible
promoter. Upon serum stimulation following 24hr starvation, we
saw robust activation of RhoC with the wildtype RhoC
biosensor (Figure 1F) but not with the PBD control. The MEFs
also showed clear differences in the localization of RhoA and
RhoC activity. The RhoA biosensor was maximally activated in
a narrow band 0-1 microns from the edge of extending
protrusions (Figure 2A) while RhoC showed more
heterogeneous and diffuse activation throughout the region
from the edge to several microns away from the edge (Figure
2A; Movies 1-4).
There were also striking differences between RhoC and
RhoA during macropinocytosis (Figure 2B). As reported
previously, RhoA activation was attenuated in the actin-rich
ring structure that precedes vesicle closure, and a burst of
RhoA activity appeared on the vesicle after closure [9]. In
contrast, RhoC activity was high in the ring prior to closure, and
no burst of activity was observed (Movies S5 and S6; n=5
events). With T19N dominant negative control biosensors,
RhoC showed no activation in the ring (n= 5 events) and the
burst of RhoA activation was reduced by 50% (WT: average
29.35% change, n=14 events, SD 7.18; T19N: average 15.66%
change, n=12 events, SD 6.74).
We focused on comparing RhoC and RhoA activation in the
constitutive protrusions of migrating MEFs, where RhoA activity
had previously been extensively characterized using the RhoA
FLARE.sc biosensor [9,10]. To quantify differences in RhoA
and RhoC activity, we turned to the computational multiplexing
approach described in Machacek et al., 2009. This method
Figure 2.  Imaging of the RhoC FLARE.sc biosensor (A).  RhoA (left) and RhoC activity (right) in MEFs plated on fibronectin.
RhoA scale bar = 30 µm, 15 μm in zoomed images RhoC scale bar = 20 µm, 10 μm in zoomed images. Note the fine band of
white/red at the edge of RhoA cells. (B) Biosensor emission ratios and corresponding DIC images during macropinocytosis. Arrows
highlight RhoA activity during vesicle closure and RhoC activity in the actin cup prior to closure. Width of each panel is 20 µm.
doi: 10.1371/journal.pone.0079877.g002
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Figure 3.  Correlation of RhoA/C activation and cell edge dynamics.  (A) Top: 2.5 µm width, 0.9 µm depth sampling windows
(yellow) are placed at fixed distances from the edge of a MEF expressing the RhoC biosensor. (B) Correlation of each biosensor
and cell edge velocity as a function of time and distance from the edge. Inset legend indicates color code for spatial zones. RhoA:
n=16 cells, 993 windows, RhoC: n=16 cells, 869 windows. Correlation coefficients (C) and time shifts (D) for RhoA (open) and RhoC
(solid) at different distances from the edge. Error bars represent 95% confidence intervals, estimated by bootstrap analysis of
variation in the correlation functions.
doi: 10.1371/journal.pone.0079877.g003
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uses cell edge velocity as a common reference to relate, in
time and space, the activities of two different biosensors
studied in separate experiments. The first step in computational
multiplexing is to determine the spatiotemporal correlation
between cell edge movement and each of the biosensors
separately. As illustrated in Figure 3A and Movie 7 for RhoC,
GTPase activity was probed in reporter windows which
followed the edge during protrusion and retraction events. For
each window we obtained a time series of edge velocity and a
time series of GTPase activity, allowing us to determine by
Pearson’s cross-correlation the tightness of coupling and the
time lag between protein activity and edge motion. Importantly,
as the correlation is computed locally, these relationships are
captured despite the asynchronous motion of different edge
sectors. This analysis is completely invariant with respect to
cell shape and largely insensitive to the heterogeneity of
morphodynamic behaviors between cells. However, the
correlation analysis from only a single window would be too
noisy to determine unambiguous relationships. Therefore, we
take all windows from all cells and perform a cubic spline fit to
obtain the mean correlation, followed by 2000 bootstrap
samplings of the residuals from per-window correlations
relative to spline, to obtain the confidence intervals about the
mean (RhoA: n=16 cells, 993 windows, RhoC: n=16 cells, 869
windows). This procedure was repeated for windows at
different distances from the edge, allowing us to determine how
the correlation changes with the location of the signaling
activity. The second step in computational multiplexing is to
compare the correlation functions of multiple Rho GTPases. As
each of the functions uses the edge velocity as a reference, the
differences between the functions indicate directly
spatiotemporal differences between the Rho GTPases.
Using this approach we first sought to identify subcellular
regions where RhoA and RhoC differed during protrusion. In
agreement with previous data [9,10], RhoA activity showed
statistically significant, maximal positive correlation with edge
velocity at a zone 0.9-1.9 μm from the cell edge ( r ~0.15), with
a 29 sec (confidence interval, +/- 7 sec) mean time lag (Figure
3B, left). Analysis of RhoA activity in reporter windows
successively further from the cell edge revealed decreasing yet
still positive correlation (Figure 3B,C). The time lags steadily
decreased to more negative values further from the edge
(Figure 3B, D). This means that with greater distance from the
edge RhoA activity is modulated with a delay relative to edge
motion, consistent with the notion that active RhoA molecules
or upstream activators (e.g. GEFs) diffuse from the site of initial
activation at the cell edge.
RhoC also showed strongest correlation with edge velocity at
0.9-1.9 μm from the cell edge, with a time lag not statistically
different from that observed for RhoA (r~0.125, Figure 3B,
right). This positive correlation with edge velocity for RhoC
mimics the trend observed for RhoA, decreasing with distances
greater than 1.9 μm from the edge. Interestingly, while the time
lag between RhoA activation and edge velocity remained
negative regardless of spatial zone, RhoC by contrast had
negative time lag values at the cell edge but positive time lag
values at all zones measured greater than 0.9 μm from the cell
edge (Figure 3B right, Figure 3D). This indicated that in this
region RhoC activity is modulated slightly before a
corresponding modulation in edge motion, while RhoA activity
is modulated afterwards. Together these data show that RhoA
and RhoC are differentially regulated in cell protrusions, with
distinct kinetics in five spatial zones defined by their distance
from the cell edge.
A multitude of RhoA/C isoform-specific functions and
differential RhoA/C regulation have been described in the
context of oncogenesis and metastasis. During EMT, RhoA
activation was shown to be attenuated with a concomitant
increase in RhoC expression [28]. In metastatic prostate
cancer, RhoC interacts preferentially with the kinase PKN3
[29]. p38 gamma MAPK regulates breast cancer cell migration
by controlling the ubiquitination of RhoC but not RhoA [30].
Also in the breast cancer paradigm, alpha 2 beta 1 integrins
were found to be modulated specifically by RhoC in
MDAMB231 cells [31]. RhoA was found to be primarily
cytoplasmic while predominant membrane localization was
observed for RhoC in pancreatic cancer cells, resulting in an
opposing effect on cell migration and invasion [32]. Finally,
microRNAs have been ascribed to the direct or indirect
regulation of RhoC expression [33], with analogous examples
elucidated for RhoA [34,35].
Despite such increasing evidence for RhoA/C isoform-
specific functions, other studies have provided evidence for
A/C isoform functional redundancy. Biallelic loss of RhoA in
mouse fibroblasts resulted in no significant actin cytoskeleton
abnormalities, suggesting that RhoC can functionally
compensate [36]. It is thought that RhoA and RhoC are equally
regulated by most Rho GEFs without isoform discrimination,
including MyoGEF in breast cancer cells [37]. As one example
of common effectors, PRK2 kinase is downstream of both
RhoA and RhoC to regulate junctional integrity [38].
It is likely that the utilization of different RhoA/C functions by
cells is contextual, where tumor microenvironment as well as
cell autonomous factors contribute. Our work described here
provides evidence for RhoA/C functional divergence, and
importantly, does so at the level of GTPase activity, as
opposed to analysis solely at the level of protein or mRNA
levels. The differential kinetics of activation revealed by RhoA
and RhoC FLARE.sc here may reflect a prominent role for
RhoC in regulating myosin contractility at actomyosin
contraction modules [39], and timing of associated actomyosin
network disassembly [40]. Clearly, the use of RhoC FLARE.sc
and other approaches to examine RhoA/C activity must be
extended to cancer cell lines and ultimately to in vivo models
on oncogenesis for a comprehensive understanding of
differential isoform functions.
It is important to note that the RhoC biosensor, like the other
FLARE biosensors [20], is designed with its C-terminal
hypervariable region intact and unencumbered by an attached
fluorescent protein. This maintains interaction with guanosine
dissociation inhibitors (GDI) and regulation of reversible
membrane translocation. Biosensors where the C terminus is
modified have proven useful as indicators of upstream GEF
activity, but do not necessarily reflect all negative regulatory
inputs. Such biosensors can produce FRET that indicates
localized GEF activity where endogenous GTPase may not in
RhoA/C Biosensors in Cell Protrusion
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fact be active. The ability of the FLARE sensors to report
negative regulation can render cells sensitive to high levels of
expression. Careful titration to determine appropriate levels is
important [10,19]. Perhaps the most challenging aspect of
biosensor imaging is maintaining cell health in the face of
irradiation, manipulation and expression of ectopic protein.
Dual chain biosensors [10] are in general more sensitive than
single chain biosensors, because the single chain sensors’
FRET is not fully abrogated in the off state. In comparison to
the dynamic range of the single chain RhoA FLARE (55.5%
between WT vs. WT+GDI) [9] and the single chain RhoC
FLARE biosensor described here (50.1% between WT vs WT
+GDI; Figure 1B), dual chain biosensors have a very large
range (ranging from no FRET to some positive value). The
measurable range of dual chain biosensors is limited by the
signal/noise of the imaging system. Improved dual chain
designs are currently under development in our laboratories.
In summary, we report here the development of RhoC
FLARE.sc, a new single-chain biosensor for RhoC, capable of
detecting the isoform-specific activation dynamics of Rho
GTPases at unprecedented resolution during cell protrusion.
Spatially, both RhoA and RhoC are maximally activated 0.9-1.9
µm from the cell edge during protrusion. These activations
occur with different kinetics, in that RhoC activation occurs
before protrusive events are initiated, while RhoA activation
slightly lags behind the motion of the leading edge. These
differences in activation dynamics begin to point to functionally
divergent roles of these two close isoforms of Rho GTPases.
Additional work will be necessary to identify the mechanisms
by which the differential activation kinetics of RhoA and RhoC
are orchestrated during cell motility. The identification of
additional GEFs that discriminate between RhoA and RhoC, as
well as the identification of RhoC-specific effectors like FMLN2
[41] and MLK-related kinase [42], will aid in elucidating these
mechanisms.
Supporting Information
Appendix S1.  Biosensor base sequence and
corresponding amino acid sequence.
(DOC)
Figure S1.  Biosensor domain diagram and amino acid
sequence.
(TIF)
Movie S1.  RhoA activity at the edge of a MEF cell plated
on 5 µg/ml fibronectin. Activity is maximal at the region
immediately adjacent to the cell edge and largely restricted to
this region. Duration of original sequence: 30 min.
Magnification 40X, 2X2 binning. Frame interval: 60 sec.
Replay: 10 frames/sec. Scale bar: 10 µm. Color bar defines the
dynamic range of the FRET/CFP ratio. See Figure 2A.
(MOV)
Movie S2.  Additional example of RhoA activity at the edge
of a MEF cell plated on 5 µg/ml fibronectin. Duration of
original sequence: 30 min. Magnification 40X, 2X2 binning.
Frame interval: 60 sec. Replay: 5 frames/sec. Scale bar: 10
µm. Color bar defines the dynamic range of the FRET/CFP
ratio. See Figure 2A.
(MOV)
Movie S3.  RhoC activity at the edge of a MEF plated on 5
µg/ml fibronectin. Activation is seen both at the edge and at
variable regions within the cell. Duration of original sequence:
20 min. Magnification 40X, 2X2 binning. Frame interval: 10 sec.
Replay: 10 frames/sec. Scale bar: 10 µm. Color bar defines the
dynamic range of the FRET/CFP ratio. See Figure 2A.
(MOV)
Movie S4.  Additional example of RhoC activity at the edge
of a MEF plated on 5 µg/ml fibronectin. Duration of original
sequence: 20 min. Magnification 40X, 2X2 binning. Frame
interval: 10 sec. Replay: 10 frames/sec. Scale bar: 10 µm.
Color bar defines the dynamic range of the FRET/CFP ratio.
See Figure 2A.
(MOV)
Movie S5.  RhoA activity and corresponding DIC of a MEF
undergoing macropinocytosis. Note burst of activation
accompanying vesicle closure. Duration of original sequence:
30 min. Magnification 40X, 2X2 binning. Frame interval: 60 sec.
Replay: 5 frames/sec. Scale bar: 10 µm. Color bar defines the
dynamic range of the FRET/CFP ratio. See Figure 2B.
(MOV)
Movie S6.  RhoC activity and corresponding DIC of a MEF
undergoing macropinocytosis. Note activation within actin
structures preceding closure. Duration of original sequence: 45
min. Displaying frames #145-245. Magnification 40X, 2X2
binning. Frame interval: 10 sec. Replay: 10 frames/sec. Scale
bar: 10 µm. Color bar defines the dynamic range of the
FRET/CFP ratio. See Figure 2B.
(MOV)
Movie S7.  Overlay of sampling windows and velocity
vectors for a MEF expressing the RhoC biosensor. For
correlation of RhoC activity and cell edge velocity, 2.5 µm
width, 0.9 µm depth sampling windows (yellow) are placed at
fixed distances relative to the edge. Green lines indicate
velocity vectors. Duration of original sequence: 20 min.
Magnification 40X, 2X2 binning. Frame interval: 10 sec.
Replay: 10 frames/sec. See Figure 3A.
(MOV)
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